South America Liver Cancer Diagnostics Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 – COVID-19 Impact and Analysis – by Type (Laboratory Tests, Endoscopy, Imaging, Biopsy, and Others) and End User (Hospitals and Diagnostic Laboratories, Academic and Research Institutes, and CRO Laboratories)

No. of Pages: 129    |    Report Code: BMIRE00025044    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
South America Liver Cancer Diagnostics Market

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        South America Liver Cancer Diagnostics Market – By Type

1.3.2        South America Liver Cancer Diagnostics Market – By End User

1.3.3        South America Liver Cancer Diagnostics Market – By Country

2.           South America Liver Cancer Diagnostics Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           South America Liver Cancer Diagnostics Market Landscape

4.1         Overview

4.2         PEST Analysis

4.3         Experts Opinion

5.           South America Liver Cancer Diagnostics Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Heighten Prevalence of Liver Cancer

5.2         Market Restraints

5.2.1        Exorbitant Cost of Technologically Advanced Liver Cancer Diagnostic Solutions

5.3         Market Opportunities

5.3.1        Fostering Demand for Point-of-Care Testing

5.4         Future Trends

5.4.1        Rooting Emergence of New Technologies

5.5         Impact Analysis

6.           South America Liver Cancer Diagnostics Market Analysis

6.1         South America Liver Cancer Diagnostics Market Revenue Forecast and Analysis

7.           South America Liver Cancer Diagnostics Market Analysis – By Type

7.1         Overview

7.2         South America Liver Cancer Diagnostics Market Revenue Share, by Type (2021 and 2028)

7.3         Laboratory Tests

7.3.1        Overview

7.3.2        Laboratory Tests: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.1          Blood Tests

7.3.2.1.1          Overview

7.3.2.1.2          Blood Tests: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.2          Biomarkers

7.3.2.2.1          Overview

7.3.2.2.2          Biomarkers: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Endoscopy

7.4.1        Overview

7.4.2        Endoscopy: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Imaging

7.5.1        Overview

7.5.2        Imaging: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.6         Biopsy

7.6.1        Overview

7.6.2        Biopsy: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.7         Others

7.7.1        Overview

7.7.2        Others: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.           South America Liver Cancer Diagnostics Market Analysis – By End User

8.1         Overview

8.2         South America Liver Cancer Diagnostics Market Revenue Share, By End User (2021 and 2028)

8.3         Hospitals and Diagnostics Laboratories

8.3.1        Overview

8.3.2        Hospitals and Diagnostics Laboratories: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Academic and Research Institutes

8.4.1        Overview

8.4.2        Academic and Research Institutes: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.5         CRO Laboratories

8.5.1        Overview

8.5.2        CRO Laboratories: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.           South America Liver Cancer Diagnostics Market – Country Analysis

9.1         Overview

9.1.1        South America: Liver Cancer Diagnostics Market Share by Country – 2021 & 2028, (%)

9.1.1.1          Brazil: Liver Cancer Diagnostics Market- Revenue and Forecasts To 2028 (USD Million)

9.1.1.1.1          Overview

9.1.1.1.2          Brazil: Liver Cancer Diagnostics Market- Revenue and Forecasts to 2028 (USD Million)

9.1.1.1.3          Brazil Liver Cancer Diagnostics Market, By Type– Revenue and Forecast to 2028 (USD Million)

9.1.1.1.3.1        Brazil Liver Cancer Diagnostics Market, By Laboratory Tests – Revenue and Forecast to 2028 (USD Million)

9.1.1.1.4          Brazil Liver Cancer Diagnostics Market, By End User – Revenue and Forecast to 2028 (USD Million)

9.1.1.2          Argentina: Liver Cancer Diagnostics Market- Revenue and Forecasts To 2028 (USD Million)

9.1.1.2.1          Overview

9.1.1.2.2          Argentina: Liver Cancer Diagnostics Market- Revenue and Forecasts To 2028 (USD Million)

9.1.1.2.3          Argentina Liver Cancer Diagnostics Market, By Type– Revenue and Forecast to 2028 (USD Million)

9.1.1.2.3.1        Argentina Liver Cancer Diagnostics Market, By Laboratory Tests – Revenue and Forecast to 2028 (USD Million)

9.1.1.2.4          Argentina Liver Cancer Diagnostics Market, By End User – Revenue and Forecast to 2028 (USD Million)

9.1.1.3          Rest of SAM: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

9.1.1.3.1          Overview

9.1.1.3.2          Rest of SAM: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

9.1.1.3.3          Rest of SAM Liver Cancer Diagnostics Market, By Type– Revenue and Forecast to 2028 (USD Million)

9.1.1.3.3.1        Rest of SAM Liver Cancer Diagnostics Market, By Laboratory Tests – Revenue and Forecast to 2028 (USD Million)

9.1.1.3.4          Rest of SAM Liver Cancer Diagnostics Market, By End User – Revenue and Forecast to 2028 (USD Million)

10.        South America Liver Cancer Diagnostics Market– Industry Landscape

10.1      Overview

10.2      Organic Developments

10.2.1     Overview

10.3      Inorganic Developments

10.3.1     Overview

11.        Company Profiles

11.1      Abbott

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2      bioMerieux SA

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3      F. HOFFMANN-LA ROCHE LTD.

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4      Illumina, Inc.

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5      Koninklijke Philips N.V.

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Products and Services

11.5.4     Financial Overview

11.5.5     SWOT Analysis

11.5.6     Key Developments

11.6      QIAGEN

11.6.1     Key Facts

11.6.2     Business Description

11.6.3     Products and Services

11.6.4     Financial Overview

11.6.5     SWOT Analysis

11.6.6     Key Developments

11.7      Siemens Healthineers AG

11.7.1     Key Facts

11.7.2     Business Description

11.7.3     Products and Services

11.7.4     Financial Overview

11.7.5     SWOT Analysis

11.7.6     Key Developments

11.8      THERMO FISHER SCIENTIFIC INC.

11.8.1     Key Facts

11.8.2     Business Description

11.8.3     Products and Services

11.8.4     Financial Overview

11.8.5     SWOT Analysis

11.8.6     Key Developments

11.9      GE Healthcare

11.9.1     Key Facts

11.9.2     Business Description

11.9.3     Products and Services

11.9.4     Financial Overview

11.9.5     SWOT Analysis

11.9.6     Key Developments

11.10   Perspectum

11.10.1  Key Facts

11.10.2  Business Description

11.10.3  Products and Services

11.10.4  Financial Overview

11.10.5  SWOT Analysis

11.10.6  Key Developments

12.        Appendix

12.1      About The Insight Partners

12.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             Brazil Liver Cancer Diagnostics Market, By Type– Revenue and Forecast to 2028 (USD Million)

Table 2.             Brazil Liver Cancer Diagnostics Market, By Laboratory Tests – Revenue and Forecast to 2028 (USD Million)

Table 3.             Brazil Liver Cancer Diagnostics Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 4.             Argentina Liver Cancer Diagnostics Market, By Type– Revenue and Forecast to 2028 (USD Million)

Table 5.             Argentina Liver Cancer Diagnostics Market, By Laboratory Tests – Revenue and Forecast to 2028 (USD Million)

Table 6.             Argentina Liver Cancer Diagnostics Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 7.             Rest of SAM Liver Cancer Diagnostics Market, By Type– Revenue and Forecast to 2028 (USD Million)

Table 8.             Rest of SAM Liver Cancer Diagnostics Market, By Laboratory Tests – Revenue and Forecast to 2028 (USD Million)

Table 9.             Rest of SAM Liver Cancer Diagnostics Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 10.          Organic Developments in the Liver Cancer Diagnostics Market

Table 11.          Inorganic Developments in the Liver Cancer Diagnostics Market

Table 12.          Glossary of Terms

 


LIST OF FIGURES

Figure 1.           South America Liver Cancer Diagnostics Market Segmentation

Figure 2.           South America Liver Cancer Diagnostics Market Segmentation, By Country

Figure 3.           South America Liver Cancer Diagnostics Market Overview

Figure 4.           Laboratory Tests Segment Held Largest Share by Type in South America Liver Cancer Diagnostics Market

Figure 5.           Argentina Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           South America Liver Cancer Diagnostics Market, Industry Landscape

Figure 7.           South America: PEST Analysis

Figure 8.           Experts Opinion

Figure 9.           Impact Analysis of Drivers and Restraint Pertaining to South America Liver Cancer Diagnostics Market

Figure 10.        South America Liver Cancer Diagnostics Market – Revenue Forecast and Analysis – 2021- 2028

Figure 11.        South America Liver Cancer Diagnostics Market Revenue Share, by Type (2021 and 2028)

Figure 12.        Laboratory Tests: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Blood Tests: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Biomarkers: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Endoscopy: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Imaging: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Biopsy: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Others: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        South America Liver Cancer Diagnostics Market Revenue Share, By End User (2021 and 2028)

Figure 20.        Hospitals and Diagnostics Laboratories: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Academic and Research Institutes: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        CRO Laboratories: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        South America: Liver Cancer Diagnostics Market, By Key Country – Revenue (2021) (USD Million)

Figure 24.        South America: Liver Cancer Diagnostics Market Share by Country – 2021 & 2028, (%)

Figure 25.        Brazil: Liver Cancer Diagnostics Market- Revenue and Forecasts to 2028 (USD Million)

Figure 26.        Argentina: Liver Cancer Diagnostics Market- Revenue and Forecasts To 2028 (USD Million)

Figure 27.        Rest of SAM: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

The List of Companies - South America Liver Cancer Diagnostics Market

  1. Abbott
  2. bioMerieux SA
  3. F. HOFFMANN-LA ROCHE LTD.
  4. Illumina, Inc.
  5. Koninklijke Philips N.V.
  6. QIAGEN
  7. Siemens Healthineers AG
  8. THERMO FISHER SCIENTIFIC INC.
  9. GE Healthcare
  10. Perspectum